Fremman Capital-backed Amethyst completed the acquisition of Stingray Healthcare from Jacobs Capital.

Fremman Capital-backed Amethyst, a network of radiotherapy centers, completed the acquisition of Stingray Healthcare, an innovative partnership-based cancer care center, from Jacobs Capital, an investment firm. Financial terms were not disclosed. “We are very proud of what we have achieved with Stingray. The doctor-centric business model has proven to be highly successful as it promotes innovation and growth, and supports excellent patient care and outcomes,” Philippe Jacobs, Jacobs Co-Chairman and Founder.